Correlation Between Stoke Therapeutics and Krystal Biotech
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Krystal Biotech, you can compare the effects of market volatilities on Stoke Therapeutics and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Krystal Biotech.
Diversification Opportunities for Stoke Therapeutics and Krystal Biotech
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Krystal is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Krystal Biotech go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Krystal Biotech
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.01 times less return on investment than Krystal Biotech. In addition to that, Stoke Therapeutics is 1.82 times more volatile than Krystal Biotech. It trades about 0.03 of its total potential returns per unit of risk. Krystal Biotech is currently generating about 0.05 per unit of volatility. If you would invest 12,800 in Krystal Biotech on August 31, 2024 and sell it today you would earn a total of 6,942 from holding Krystal Biotech or generate 54.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Krystal Biotech
Performance |
| Timeline |
| Stoke Therapeutics |
| Krystal Biotech |
Stoke Therapeutics and Krystal Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Krystal Biotech
The main advantage of trading using opposite Stoke Therapeutics and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |